WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 14.4 HKD -4% Market Closed
Market Cap: 59.8B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
WuXi Biologics (Cayman) Inc

Current Assets 19.8B
Cash & Short-Term Investments 9.5B
Receivables 6.8B
Other Current Assets 3.4B
Non-Current Assets 36.3B
Long-Term Investments 2.8B
PP&E 30.8B
Intangibles 2B
Other Non-Current Assets 700.4m
Current Liabilities 6.8B
Accounts Payable 3.1B
Accrued Liabilities 393.2m
Other Current Liabilities 3.4B
Non-Current Liabilities 8.6B
Long-Term Debt 3.5B
Other Non-Current Liabilities 5.2B

Balance Sheet
WuXi Biologics (Cayman) Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
158
169
504
4 084
6 205
7 096
9 003
6 395
9 670
Cash
0
0
0
0
0
0
7 096
9 003
6 395
9 670
Cash Equivalents
6
158
169
504
4 084
6 205
0
0
0
0
Short-Term Investments
0
0
0
1 556
0
543
1 385
2 123
2 319
1 574
Total Receivables
160
283
420
613
1 101
1 773
3 122
4 851
6 126
6 783
Accounts Receivables
131
190
294
314
799
1 375
2 357
3 256
5 144
6 153
Other Receivables
30
93
126
299
302
398
765
1 595
982
630
Inventory
62
151
202
338
227
399
1 084
1 687
2 281
1 766
Other Current Assets
1
9
39
22
333
751
1 518
1 865
1 348
1 406
Total Current Assets
229
601
830
3 033
5 745
9 672
14 204
19 530
18 470
21 198
PP&E Net
405
754
1 153
1 780
2 904
6 796
12 870
19 756
25 916
29 939
PP&E Gross
405
754
1 153
1 780
2 904
6 796
12 870
19 756
25 916
29 939
Accumulated Depreciation
78
135
227
349
557
829
1 183
1 696
2 488
3 557
Intangible Assets
0
0
0
0
332
416
392
601
549
512
Goodwill
0
0
0
0
0
185
185
1 530
1 530
1 530
Note Receivable
0
0
0
0
0
0
88
124
109
166
Long-Term Investments
0
0
0
17
192
452
1 074
2 203
2 709
2 934
Other Long-Term Assets
3
2
2
18
220
81
150
289
281
296
Other Assets
0
0
0
0
0
185
185
1 530
1 530
1 530
Total Assets
637
N/A
1 357
+113%
1 985
+46%
4 849
+144%
9 393
+94%
17 602
+87%
28 964
+65%
44 033
+52%
49 564
+13%
56 576
+14%
Liabilities
Accounts Payable
147
271
105
137
221
186
646
618
794
3 589
Accrued Liabilities
4
37
56
85
142
257
501
781
913
707
Short-Term Debt
51
456
183
0
0
506
767
2 122
0
0
Current Portion of Long-Term Debt
0
0
50
0
0
26
61
104
1 470
731
Other Current Liabilities
55
438
406
576
956
1 896
2 523
4 631
6 141
5 364
Total Current Liabilities
261
1 202
801
798
1 319
2 871
4 498
8 256
9 319
7 636
Long-Term Debt
0
0
896
0
0
1 661
2 504
2 070
2 951
3 830
Deferred Income Tax
0
0
5
7
3
25
181
124
132
123
Minority Interest
0
0
0
0
0
112
335
428
1 166
3 686
Other Liabilities
4
9
13
20
77
149
881
877
949
969
Total Liabilities
265
N/A
1 211
+357%
1 715
+42%
825
-52%
1 399
+70%
4 818
+244%
8 399
+74%
11 754
+40%
14 517
+24%
16 244
+12%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
372
146
270
588
1 332
2 511
4 405
8 233
13 585
17 608
Additional Paid In Capital
0
0
0
3 436
6 650
10 260
15 950
27 044
22 102
24 489
Unrealized Security Profit/Loss
0
0
0
0
0
0
3
33
92
113
Treasury Stock
0
0
0
0
0
0
0
2 517
0
917
Other Equity
0
0
0
0
12
13
212
449
547
735
Total Equity
372
N/A
146
-61%
270
+85%
4 024
+1 388%
7 994
+99%
12 784
+60%
20 564
+61%
32 279
+57%
35 047
+9%
40 332
+15%
Total Liabilities & Equity
637
N/A
1 357
+113%
1 985
+46%
4 849
+144%
9 393
+94%
17 602
+87%
28 964
+65%
44 033
+52%
49 564
+13%
56 576
+14%
Shares Outstanding
Common Shares Outstanding
964
2 892
2 892
3 489
3 678
3 884
4 085
4 259
4 225
4 240

See Also

Discover More